BDBM226862 US9328096, 555
SMILES: Fc1cccnc1-c1cc(C(=O)Nc2cc(nn2-c2ccccc2)C(=O)N[C@@H]2CCOC2)c(Cl)cc1Cl
InChI Key: InChIKey=AADGFLAQHXJJRJ-OAHLLOKOSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tyrosine kinase receptor A (TrkA) (Homo sapiens (Human)) | BDBM226862 (US9328096, 555) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.41 | n/a | n/a | n/a | n/a | n/a | 37 |
Pfizer Inc. US Patent | Assay Description TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR... | US Patent US9328096 (2016) BindingDB Entry DOI: 10.7270/Q2FN152J | |||||||||||
More data for this Ligand-Target Pair |